What it takes to make cancer research more inclusive
Drug Discovery World
AUGUST 16, 2022
In recent years, governments, institutes, pharma companies, and funding bodies have taken significant measures to proactively address cancer disparities. However, these social categories are rather arbitrary and don’t necessarily correspond to the underlying molecular biology of the patient, risking misguided clinical care.
130 
Let's personalize your content